[1]任雨欣.煤工塵肺合并COPD患者長期規則使用舒利迭的效果[J].醫學信息,2020,(04):147-148.[doi:10.3969/j.issn.1006-1959.2020.04.047]
 REN Yu-xin.Effect of Long-term Regular Use of Seretide in Patients with Coal Worker Pneumoconiosis and COPD[J].Medical Information,2020,(04):147-148.[doi:10.3969/j.issn.1006-1959.2020.04.047]
點擊復制

煤工塵肺合并COPD患者長期規則使用舒利迭的效果()
分享到:

醫學信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期數:
2020年04期
頁碼:
147-148
欄目:
藥物與臨床
出版日期:
2020-02-15

文章信息/Info

Title:
Effect of Long-term Regular Use of Seretide in Patients with Coal Worker Pneumoconiosis and COPD
文章編號:
1006-1959(2020)04-0147-02
作者:
任雨欣
(國家衛生健康委職業安全衛生研究中心呼吸科,北京 102300)
Author(s):
REN Yu-xin
(Department of Respiratory Medicine,Occupational Safety and Health Research Center,National Health Council,Beijing 102300,China)
關鍵詞:
煤工塵肺COPD舒利迭
Keywords:
Coal worker pneumoconiosisCOPDLong-termSeretide
分類號:
R966
DOI:
10.3969/j.issn.1006-1959.2020.04.047
文獻標志碼:
A
摘要:
目的 分析長期規則運用舒利迭對煤工塵肺合并慢性阻塞性肺疾。–OPD)患者的臨床療效。方法 選取2018年3月~2019年3月在本院收治的煤工塵肺合并COPD患者120例為研究對象,采用隨機抽樣法將其分成對照組和研究組,各60例。對照組采用沙丁胺醇吸入治療,研究組在對照組的基礎上給予舒利迭治療。比較兩組炎癥因子水平以及凝血功能。結果 治療后研究組血清IL-1水平為(123.51±8.57)ρ/μg·L-1,高于對照組的(89.49±8.62)ρ/μg·L-1,而IFN為(125.11±8.37),低于對照組的(186.36±12.54),差異具有統計學意義(P<0.05);研究組D-二聚體、Fib、PLT分別為(0.47±0.28)mg/L、(3.78±0.42)g/L、(345.51±62.27)×109/L,低于對照組的(0.86±0.35)mg/L 、(4.58±0.63)g/L、(415.45±53.28)×109/L,差異具有統計學意義(P<0.05)。結論 采用舒利迭治療煤工塵肺合并COPD療效滿意,有助于改善患者的凝血功能,降低血D-二聚體 、Fib及PLT,提高其血清IL-1水平,值得應用。
Abstract:
Objective To analyze the clinical efficacy of long-term regular application of Seretide in patients with coal worker pneumoconiosis with chronic obstructive pulmonary disease (COPD).Methods A total of 120 patients with coal workers’ pneumoconiosis and COPD who were treated in our hospital from March 2018 to March 2019 were selected as the research subjects. They were randomly divided into a control group and a research group, each with 60 patients. The control group was treated with salbutamol inhalation, and the study group was given Seretide therapy on the basis of the control group. The levels of inflammatory factors and coagulation function were compared between the two groups.Results After treatment, the serum IL-1 level in the study group was (123.51±8.57) ρ/μg·L-1, which was higher than that of the control group (89.49±8.62) ρ/μg·L-1, and the IFN was (125.11±8.37),(186.36±12.54) lower than the control group, the difference was statistically significant (P<0.05); D-dimer, Fib, and PLT in the study group were (0.47±0.28)mg/L, (3.78±0.42 )g/L, (345.51±62.27)×109/L, (0.86±0.35)mg/L, (4.58±0.63)g/L, (415.45±53.28)×109/L lower than the control group,the difference was statistically significant(P<0.05).Conclusion The use of Seretide in the treatment of coal worker pneumoconiosis with COPD is satisfactory, which helps to improve the patient’s coagulation function, reduce blood D-dimer, Fib and PLT, and increase its serum IL-1 level, which is worthy of application.

參考文獻/References:

[1]鄭文旭,張鳳革,張曉靜,等.加用舒利迭對哮喘合并COPD患者FEV、PEF水平及T淋巴細胞分化的影響分析[J].湖南師范大學學報(醫學版),2019,16(1):50-53. [2]劉春濤,馮玉麟.慢性阻塞性肺疾病全球創議慢性阻塞性肺疾病診斷、管理和預防袖珍指南(2006年修訂版)[J].中國呼吸與危重監護雜志,2007,6(3):230-237. [3]顧國強,鄧澤林,梁錦.布地奈德霧化吸入聯合舒利迭治療慢性阻塞性肺疾病(COPD)合并感染患者臨床效果[J].現代診斷與治療,2017,69(10):82-83. [4]趙麗格,閆佳強,李富東,等.COPD穩定期患者以噻托溴銨聯合舒利迭治療的效果分析[J].國際醫藥衛生導報,2018,24(12):1849-1851. [5]馬瑋華.布地奈德霧化吸入聯合舒利迭對COPD合并感染患者的臨床影響分析[J].系統醫學,2017,2(18):39-40. [6]孫成勇.舒利迭對煤工塵肺合并慢性阻塞性肺疾病患者肺功能的影響[J].臨床肺科雜志,2017,16(2):309.

相似文獻/References:

[1]馬建娟.布地奈德聯合異丙托溴銨霧化治療COPD 急性加重期的效果評價[J].醫學信息,2018,(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
 MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Medical Information,2018,(04):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
[2]任慶玲.聚焦解決模式對慢阻肺患者主要照顧者的 照顧負擔及負性情緒影響的研究[J].醫學信息,2018,(07):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
 REN Qing-ling.Study on the Effect of Focus-resolving Model on the Burden of Care and Negative Emotions of Primary Caregivers in Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,(04):162.[doi:10.3969/j.issn.1006-1959.2018.07.057]
[3]林 楊,蘇志強,鮑 靖,等.ICF核心分類聯合mMRC用于COPD患者康復效果的研究[J].醫學信息,2019,(03):175.[doi:10.3969/j.issn.1006-1959.2019.03.060]
 LIN Yang,SU Zhi-qiang,BAO Jing,et al.Effect of ICF Core Classification Combined with mMRC on Rehabilitation of COPD Patients[J].Medical Information,2019,(04):175.[doi:10.3969/j.issn.1006-1959.2019.03.060]
[4]梁雪梅,蔡曉玉,王 真,等.綜合護理措施對無創呼吸機治療COPD合并呼吸衰竭的Meta分析[J].醫學信息,2019,(05):91.[doi:10.3969/j.issn.1006-1959.2019.05.027]
 LIANG Xue-mei,CAI Xiao-yu,WANG Zhen,et al.Meta-analysis of Comprehensive Nursing Measures for Non-invasive Ventilator in the Treatment of COPD with Respiratory Failure[J].Medical Information,2019,(04):91.[doi:10.3969/j.issn.1006-1959.2019.05.027]
[5]劉怡彤,馬利軍.基于“互聯網+”的移動醫療技術在慢性阻塞性肺病穩定期管理的應用及問題研究[J].醫學信息,2019,(06):38.[doi:10.3969/j.issn.1006-1959.2019.06.014]
 LIU Yi-tong,MA Li-jun.Application and Problem Research of Mobile Medical Technology Based on"Internet +"in Stable Period Management of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,(04):38.[doi:10.3969/j.issn.1006-1959.2019.06.014]
[6]吳 鵬,徐 超,曲 紅.線性周期化訓練和非線性周期化訓練對慢性阻塞性肺疾病患者的影響[J].醫學信息,2019,(09):88.[doi:10.3969/j.issn.1006-1959.2019.09.028]
 WU Peng,XU Chao,QU Hong.Effects of Linear Periodic Training and Nonlinear Periodic Training on Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,(04):88.[doi:10.3969/j.issn.1006-1959.2019.09.028]
[7]馬宏境,劉 彬.慢性阻塞性肺疾病發病機制的研究[J].醫學信息,2019,(10):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
 MA Hong-jing,LIU Bin.Study on the Pathogenesis of Chronic Obstructive Pulmonary Disease[J].Medical Information,2019,(04):50.[doi:10.3969/j.issn.1006-1959.2019.10.018]
[8]高小燕,陳 蓉,盧慧宇.血糖控制水平對COPD伴2型糖尿病患者 肺功能及其預后的影響[J].醫學信息,2019,(16):76.[doi:10.3969/j.issn.1006-1959.2019.16.023]
 GAO Xiao-yan,CHEN Rong,LU Hui-yu.Effect of Blood Glucose Control Level on Pulmonary Function and Prognosis in Patients with COPD and Type 2 Diabetes[J].Medical Information,2019,(04):76.[doi:10.3969/j.issn.1006-1959.2019.16.023]
[9]聶 志.吸入用沙丁胺醇聯合布地奈德對COPD急性加重期的作用[J].醫學信息,2019,(22):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]
 NIE Zhi.Effect of Inhaled Salbutamol Combined with Budesonide on Acute Exacerbation of COPD[J].Medical Information,2019,(04):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]
[10]端另波,張 彤,李伯安.不同機械通氣模式對COPD合并呼吸衰竭患者氧代謝指數及血氣分析的影響[J].醫學信息,2019,(23):121.[doi:10.3969/j.issn.1006-1959.2019.23.035]
 DUAN Ling-bo,ZHANG Tong,LI Bo-an.Effects of Different Mechanical Ventilation Modes on Oxygen Metabolism Index and Blood Gas Analysis in Patients with COPD Complicated with Respiratory Failure[J].Medical Information,2019,(04):121.[doi:10.3969/j.issn.1006-1959.2019.23.035]

更新日期/Last Update: 2020-02-15
中国足彩网竞彩 山西快乐十分玩法 五分赛车技巧图片 山西快乐十分50期 广东十一选五什么时候开 东方6十1走势图带连线 广东快乐十分号码 怎样分析股票涨跌 贵州快三开奖结果 四川快乐12查询 重庆快乐10视频